Doxepin Hydrochloride

Spezifikationen

4698-39-9CAS-Nummer

214-966-8EG-Nummer

(3E)-3-(6H-benzo[c][1]benzoxepin-11-ylidene)-N,N-dimethylpropan-1-amine;hydrochlorideIUPAC-Name

C19H22ClNOChemische Formel

315.8 g/molMolekulargewicht

Doxepin Hydrochloride; 1229-29-4; Doxepin HCl; Adapin; Silenor; DTXSID8045145; 3U9A0FE9N5; DTXCID6025145; 1-Propanamine, 3-dibenz(b,e)oxepin-11(6H)ylidene-N,N-dimethyl-, hydrochloride; NSC-108160; P-3693A; NSC108160; Doxepn Hydrochloride; Hydrochloride, Doxepin; RefChem:57848; 214-966-8; (e)-doxepin hydrochloride; 4698-39-9; Doxepin (Hydrochloride); Doxepine hydrochloride; Curatin; Zonalon; Novoxapin hydrochloride; MLS000069794; CU61C5RH24; Doxepin.HCl; MF 10 HCl; Novoxapin; SMR000058230; Aponal; Toruan; Sinequan (TN); Quitaxon; Sinequin; (E)-Doxepin HCl; SR-01000075551; NCGC00015344-03; EINECS 214-966-8; CAS-1229-29-4; trans-Doxepin hydrochloride; UNII-3U9A0FE9N5; UNII-CU61C5RH24; (3-(6H-dibenzo[c,f]oxepin-11-ylidene)propyl)dimethylamine, chloride; 11-(3-Dimethylaminopropylidene)-6,11-dihydrodibenz[b,e]oxepine hydrochloride; Doxepin hydrochloride (E)-isomer; 1-Propanamine, 3-(dibenz[b,e]oxepin-11(6H)-ylidene)-N,N-dimethyl-, hydrochloride (1:1); Doxepin hydrochloride [USAN:USP]; Prestwick_187; Doxepin hydrochloride (mixture of isomers); Zonalon (TN); Opera_ID_675; (Z)-DoxepinHydrochloride; Doxepin hydrochloride CRS; 11-(3-(Dimethylamino)propylidene)-6,11-dihydrodibenz(b,e)oxepin hydrochloride; N,N-Dimethyldibenz(b,e)oxepin-delta(sup 11(6H),gamma)-propylamine hydrochloride; Doxepin hydrochloride (USP); SCHEMBL60287; MLS001148235; MLS002207250; MLS002222181; MLS002548858; E-DOXEPIN HYDROCHLORIDE; CHEBI:4711; orb1226731; CHEMBL1200462; HY-B0725R; Doxepin HCl - Bio-X trade mark; 3-(Dibenzo[b,e]oxepin-11(6H)-ylidene)-N,N-dimethylpropan-1-amine hydrochloride; MHNSPTUQQIYJOT-SJDTYFKWSA-N; HMS1568F08; HMS5081M16; Doxepin for system suitability CRS; Doxepin (Hydrochloride) (Standard); HY-B0725; MSK10048; DOXEPIN HYDROCHLORIDE, (E)-; Tox21_110130; Tox21_500339; s3120; SBB005916; AKOS015895087; Dibenz(b,e)oxepin-delta11(6H),gamma-propylamine, N,N-dimethyl-, hydrochloride; Tox21_110130_1; CCG-220263; CCG-221643; FD22604; KS-5094; LP00339; NC00447; Dibenz(b,e)oxepin-delta(sup 11(6H),gamma)-propylamine, N,N-dimethyl-, hydrochloride; NCGC00024623-04; NCGC00093778-01; NCGC00093778-02; NCGC00261024-01; BD166235; ST025239; D5994; EU-0100339; NS00076431; D 4526; D00814; Doxepin.HCl, 1mg/ml in Methanol (as free base); SR-01000075551-1; SR-01000075551-5; Q27275787; Doxepin Hydrochloride 1.0 mg/ml in Methanol (as free base); Doxepin hydrochloride, European Pharmacopoeia (EP) Reference Standard; Doxepin hydrochloride, United States Pharmacopeia (USP) Reference Standard; (3E)-3-(6H-benzo[c][1]benzoxepin-11-ylidene)-N,N-dimethyl-propan-1-amine;hydrochloride; (3E)-3-(6H-benzo[c][1]benzoxepin-11-ylidene)-N,N-dimethylpropan-1-amine;hydrochloride; Doxepin for system suitability, European Pharmacopoeia (EP) Reference Standard; Doxepin hydrochloride, ~85% E-isomer basis, >=98% (GC), 15% Z-isomer basis, powder; (3E)-3-(Dibenzo[b,e]oxepin-11(6H)-ylidene)-N,N-dimethylpropan-1-amine--hydrogen chloride (1/1); 1-PROPANAMINE, 3-DIBENZ(B,E)OXEPIN-11(6H)-YLIDENE-N,N-DIMETHYL-, HYDROCHLORIDE (1:1), (3E)-; 1-Propanamine, 3-dibenz(b,e)oxepin-11-(6H)-ylidene-N,N-dimethyl-dimethyl-, hydrochloride, (E)-; dimethyl({3-[(2E)-9-oxatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-ylidene]propyl})amine hydrochlorideSynonyme